⚡️ What’s new in healthcare this week?
A massive healthcare cyberattack hits NYC, Oura gears up for IPO, GLP-1 and women’s health platforms surge, Neuralink advances brain implants, and AI keeps reshaping care, pharma, and digital health.
Retro Biosciences is a biotechnology company focused on extending healthy human lifespan through cellular reprogramming, regenerative medicine, and autophagy research. The company develops therapies aimed at reversing age-related cellular decline and restoring tissue function, with a long-term goal of preventing diseases associated with aging rather than treating them after onset. By combining stem cell science, large-scale biology, and AI-driven research, Retro is building interventions designed to increase both lifespan and healthspan.
Hey there Insider,
Hope you had a fantastic week!
Here’s your must-read weekly roundup of the latest news and developments in the digital healthcare sector! 👇🏼
HealthEx and 23andMe partner to unify medical records and genomics.
Nourish raises $100M Series C for AI-native metabolic health clinic with GLP-1 integration.
Elon Musk’s Neuralink reveals new robotic system for BCI brain implant surgeries.
Mayo Clinic and Bayesian Health co-develop AI-powered solution to expand palliative care access.
AI ate digital health (and what that means for fundraising).
Anthropic signs enterprise AI deal with Bristol Myers Squibb.
June 9-10th | Boston, MA.
HealthSec Summit USA
Until next week, stay connected!
Digital Health Insider.










